FDA Synthesizes Feedback on LDTs in New Discussion Paper

 Email not displaying correctly? View it in your browser.
  Lab and Pathology Insider Logo  
January 17, 2017  
placeholder LDTs
FDA Synthesizes Feedback on LDTs in New Discussion Paper
Following up its decision not to issue final guidance in 2016 regarding oversight of laboratory developed tests (LDTs), the U.S. Food and Drug Administration released a…
Read More
placeholder HIPAA
First HIPAA Breach Notification Settlement Totals $475,000
Patient health information breaches—whether from hacking, glitches or just plain old carelessness…
Read More
Get a 3 month Premium Membership to one of our G2 Newsletters for just $47!
Click on one of the Newsletters below to sign up now and get unlimited access to all articles, archives, and tools for that specific newsletter!
DTET
GCA
LIR
NIR
placeholder TESTING STRATEGY
Sequencing Following Ultrasound Improves Prenatal Diagnosis
Nonsevere fetal malformations and structural abnormalities are relatively frequent findings of routine, prenatal ultrasounds. Yet, these findings provide…
Read More
placeholder EMERGING TESTS
FDA Approves Next-Gen Companion Diagnostic
A notable FDA Section 510(k) approval was granted before the close of 2016 for Foundation Medicine's FoundationFocus CDxBRCA, a next-generation sequencing-based companion diagnostic test…
Read More

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2017, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320